Watch this on-demand webinar as speakers from RxMx explain how its Chameleon platform — built on InterSystems IRIS for Health — helps clinicians who are administering new specialty medicines to their patients, meet the needs of this industry.
- Why regulators and pharmaceutical companies need to mitigate risk and implement patient adherence strategies for many new specialty therapeutics
- The role of digital adherence monitoring, analysis, and intervention in pharmaceutical development and commercialization
- How RxMx has supported solutions for managing COVID-19 test data and monitoring infusions for multiple sclerosis patients
- How a data platform designed for developing healthcare applications helps RxMx create an agile technology solution
Matt Smallcomb, Head of Product, RxMx
Tessa Angel, Head of Americas, RxMx
Matthew Stannard, Life Sciences Advisor